Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2024

Mar 12, 2024

30786_dirs_2024-03-12_9d987242-f631-49b0-a648-751d79776558.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2024-03-08

Reporting Person: MAY SIMON (EVP, President, LSG)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-08 Non-Qualified Stock Option (right to buy) $343.76 A 3535 Acquired 2034-03-08 Bio-Rad A Common Stock (3535) Direct

Footnotes

F1: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.